Documents & Downloads

Perrimustine

CysA Derivative

Perrimustine is a cysteamine (CysA) derivative that exhibits potent antitumor activity primarily through the induction of DNA damage in cancer cells. This compound demonstrates significant efficacy against B16 melanoma and metastasized melanoma cells, as well as various other malignancies including lung carcinoma, leukemia, lymphoma, colon carcinoma, and glioma in murine models. Perrimustine serves as a valuable tool for cancer research, particularly in the study of melanoma and leukemia.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	96413-13-7
Applications	CysA Derivative
Formula	C₆H₁₂ClN₃O₃S
Molecular Weight	241.70
SMILES	CS(CCNC(N(N=O)CCCl)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.